Leveraging on partnerships in accessing the markets of China, by Ms Emma Davies, #CliffordChance

Ms Emma Davies, Partner, Clifford Chance, China will be speaking at Pharma Partnering & Investments 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012

Ms Emma leads the mainland China corporate practice of Clifford Chance and the healthcare and life sciences group in Asia. She is bilingual in Mandarin and English and has spent over 15 years in Asia advising businesses on their investments in China. In addition to advising on various cross-border acquisitions and divestments for pharmaceutical and medical device companies and clients, she has assisted clients in executing collaborative agreements to co-commercialize products, including co-promote and distribution agreements between foreign life science companies in the China market.

Ms Emma Davies will be presenting on the following:

Leveraging on partnerships in accessing the markets of China
1. Examining the common challenges faced by global pharmas when accessing the markets of China
2. Licensing and partnership opportunities with Chinese companies and how to tap into this resource
3. Analyzing regulatory deterrents in China and learning what can be done to accelerate partnership deals

If you are keen to find out more, join us at BioPharma Asia Convention 2012 to gain valuable insights from more than 200 experts. Contact us now for more details!